Fidelis Capital Partners’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.58M Sell
4,811
-101
-2% -$36.3K 0.11% 156
2025
Q4
$1.73M Sell
4,912
-89
-2% -$32.4K 0.13% 134
2025
Q3
$1.85M Buy
5,001
+282
+6% +$109K 0.14% 122
2025
Q2
$1.77M Buy
4,719
+175
+4% +$65.5K 0.16% 112
2025
Q1
$1.66M Buy
4,544
+1,142
+34% +$435K 0.18% 106
2024
Q4
$1.33M Buy
3,402
+964
+40% +$357K 0.13% 132
2024
Q3
$886K Buy
2,438
+323
+15% +$111K 0.11% 165
2024
Q2
$676K Buy
2,115
+22
+1% +$7.45K 0.1% 174
2024
Q1
$749K Buy
2,093
+154
+8% +$51.8K 0.11% 166
2023
Q4
$581K Buy
1,939
+643
+50% +$180K 0.13% 155
2023
Q3
$354K Buy
1,296
+165
+15% +$47.3K 0.12% 170
2023
Q2
$345K Buy
1,131
+99
+10% +$28.6K 0.13% 172
2023
Q1
$294K Buy
+1,032
New +$274K 0.12% 183

Other funds holding SYK

Fidelis Capital Partners's SYK Position: Q1 2026 in Review

Fidelis Capital Partners reduced its Stryker (SYK) stake by 2.1% in Q1 2026, selling an estimated $36.3K and leaving 4,811 shares worth $1.58M. The position accounts for 0.11% of the portfolio, ranked #156.

Fidelis Capital Partners first reported a position in SYK in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.85M in Q3 2025. 2,294 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Fidelis Capital Partners held 4,811 shares of Stryker worth $1.58M as of Q1 2026.
  • Fidelis Capital Partners sold 101 Stryker shares in Q1 2026, an estimated $36.3K.
  • Stryker made up 0.11% of Fidelis Capital Partners's portfolio in Q1 2026, its #156 holding.
  • Fidelis Capital Partners first reported a position in Stryker in Q1 2023 and has held it in 13 quarters since.
  • Fidelis Capital Partners's Stryker position peaked at $1.85M in Q3 2025.
  • 2,294 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.